ABBV-383 plus daratumumab-dexamethasone in relapsed or refractory multiple myeloma: A phase 1b dose-escalation and safety expansion study Meeting Abstract
| Authors: | Rodriguez, C.; Mielnik, M.; Kazandjian, D.; Janowski, W.; Low, M. S. Y.; Pianko, M.; Yuda, J.; Van Der Weyden, C.; Anderson, L. D. Jr; Banerjee, R.; Dachs, L. R.; Cerchione, C.; Hultcrantz, M.; D'Souza, A.; Godara, A.; Grajales-Cruz, A.; Jin, Z.; Polepally, A. R.; Ahsan, A.; Lee, S.; D'Amico, K.; Bueno, O.; Talati, C.; Svensson, A. E.; Fleming, L.; Weisel, K. C.; Hus, M.; Voorhees, P. M. |
| Abstract Title: | ABBV-383 plus daratumumab-dexamethasone in relapsed or refractory multiple myeloma: A phase 1b dose-escalation and safety expansion study |
| Meeting Title: | 66th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 144 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2024 Dec 7-10 |
| Meeting Location: | San Diego, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2024-11-05 |
| Start Page: | 496 |
| End Page: | 498 |
| Language: | English |
| ACCESSION: | WOS:001415654100046 |
| DOI: | 10.1182/blood-2024-205083 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract -- Source: Wos |
